878 results on '"Touraine R"'
Search Results
52. Phenotypic spectrum and prevalence of INPP5E mutations in Joubert Syndrome and related disorders
- Author
-
Lorena, Travaglini, Francesco, Brancati, Jennifer, Silhavy, Miriam, Iannicelli, Elizabeth, Nickerson, Nadia, Elkhartoufi, Eric, Scott, Emily, Spencer, Stacey, Gabriel, Sophie, Thomas, Bruria, Ben Zeev, Enrico, Bertini, Eugen, Boltshauser, Malika, Chaouch, Maria, Roberta Cilio, Mirjam, M. de Jong, Hulya, Kayserili, Gonul, Ogur, Andrea, Poretti, Sabrina, Signorini, Graziella, Uziel, Maha, S. Zaki, Ali Pacha, L, Zankl, A, Leventer, R, Grattan Smith, P, Janecke, A, Koch, J, Freilinger, M, D'Hooghe, M, Sznajer, Y, Vilain, C, Van Coster, R, Demerleir, L, Dias, K, Moco, C, Moreira, A, Ae Kim, C, Maegawa, G, Dakovic, I, Loncarevic, D, Mejaski Bosnjak, V, Petkovic, D, Abdel Salam GM, Abdel Aleem, A, Marti, I, Pinard, Jm, Quijano Roy, S, Sigaudy, S, de Lonlay, P, Romano, S, Verloes, A, Touraine, R, Koenig, M, Dollfus, H, Flori, E, Fradin, M, Lagier Tourenne, C, Messer, J, Collignon, P, Penzien, Jm, Bussmann, C, Merkenschlager, A, Philippi, H, Kurlemann, G, Grundmann, K, Dacou Voutetakis, C, Kitsiou Tzeli, S, Pons, R, Jerney, J, Halldorsson, S, Johannsdottir, J, Ludvigsson, P, Phadke, Sr, Girisha, Km, Doshi, H, Udani, V, Kaul, M, Stuart, B, Magee, A, Spiegel, R, Shalev, S, Mandel, H, Lev, D, Michelson, M, Idit, M, Ben Zeev, B, Gershoni Baruch, R, Ficcadenti, A, Fischetto, R, Gentile, M, Della Monica, M, Pezzani, M, Graziano, C, Seri, M, Benedicenti, F, Stanzial, F, Borgatti, R, Romaniello, R, Accorsi, P, Battaglia, S, Fazzi, E, Giordano, L, Pinelli, L, Boccone, L, Barone, R, Sorge, G, Briatore, E, Bigoni, S, Ferlini, A, Donati, Ma, Biancheri, R, Caridi, G, Divizia, Mt, Faravelli, F, Ghiggeri, G, Mirabelli, M, Pessagno, A, Rossi, A, Uliana, V, Amorini, M, Briguglio, M, Briuglia, S, Salpietro, Cd, Tortorella, G, Adami, A, Bonati, Mt, Castorina, P, D'Arrigo, S, Lalatta, F, Marra, G, Moroni, I, Pantaleoni, C, Riva, D, Scelsa, B, Spaccini, L, Del Giudice, E, Ludwig, K, Permunian, A, Suppiej, A, Macaluso, C, Pichiecchio, A, Battini, R, Di Giacomo, M, Priolo, M, Timpani, P, Pagani, G, Di Sabato ML, Emma, F, Leuzzi, V, Mancini, F, Majore, S, Micalizzi, A, Parisi, P, Romani, M, Stringini, G, Zanni, G, Ulgheri, L, Pollazzon, M, Renieri, Alessandra, Belligni, E, Grosso, E, Pieri, I, Silengo, M, Devescovi, R, Greco, D, Romano, C, Cazzagon, M, Simonati, A, Al Tawari AA, Bastaki, L, Mégarbané, A, Sabolic Avramovska, V, Said, E, Stromme, P, Koul, R, Rajab, A, Azam, M, Barbot, C, Salih, Ma, Tabarki, B, Jocic Jakubi, B, Martorell Sampol, L, Rodriguez, B, Pascual Castroviejo, I, Gener, B, Puschmann, A, Starck, L, Capone, A, Lemke, J, Fluss, J, Niedrist, D, Hennekam, Rc, Wolf, N, Gouider Khouja, N, Kraoua, I, Ceylaner, S, Teber, S, Akgul, M, Anlar, B, Comu, S, Kayserili, H, Yüksel, A, Akcakus, M, Caglayan, Ao, Aldemir, O, Al Gazali, L, Sztriha, L, Nicholl, D, Woods, Cg, Bennett, C, Hurst, J, Sheridan, E, Barnicoat, A, Hemingway, C, Lees, M, Wakeling, E, Blair, E, Bernes, S, Sanchez, H, Clark, Ae, Demarco, E, Donahue, C, Sherr, E, Hahn, J, Sanger, Td, Gallager, Te, Daugherty, C, Krishnamoorthy, Ks, Sarco, D, Walsh, Ca, Mckanna, T, Milisa, J, Chung, Wk, De Vivo DC, Raynes, H, Schubert, R, Seward, A, Brooks, Dg, Goldstein, A, Caldwell, J, Finsecke, E, Maria, Bl, Holden, K, Cruse, Rp, Karaca, E, Swoboda, Kj, Viskochil, D, Dobyns, Wb, Colin, Johnson, Tania, Attié Bitach, Joseph, G. Gleeson, Enza, Maria Valente, ANS - Amsterdam Neuroscience, APH - Amsterdam Public Health, Human Genetics, Paediatrics, OMÜ, University of Zurich, Valente, Enza Maria, Fluss, Joel Victor, Travaglini, L, Brancati, F, Silhavy, J, Iannicelli, M, Nickerson, E, Elkhartoufi, N, Scott, E, Spencer, E, Gabriel, S, Thomas, S, Ben Zeev, B, Bertini, E, Boltshauser, E, Chaouch, M, Cilio, Mr, de Jong, Mm, Kayserili, H, Ogur, G, Poretti, A, Signorini, S, Uziel, G, Zaki, M, Johnson, C, Atti? Bitach, T, Gleeson, Jg, Valente, Em, International JSRD Study, Group, and DEL GIUDICE, Ennio
- Subjects
Male ,Ciliata -- Anatomy ,Proband ,10039 Institute of Medical Genetics ,Meckel syndrome ,RPGRIP1L ,Syndromes ,INPP5E ,MODIFIER ,Phosphoric Monoester Hydrolases/genetics ,Ciliopathies ,Polycystic Kidney Diseases/diagnosis/genetics ,CILIUM ,0302 clinical medicine ,Gene Frequency ,Cerebellum ,Prenatal Diagnosis ,RETINAL DEGENERATION ,Prevalence ,MECKEL ,ciliopathies ,Joubert syndrome and related disorders ,Eye Abnormalities ,Child ,Genetics (clinical) ,Encephalocele ,Joubert syndrome ,Genetics ,Polycystic Kidney Diseases ,0303 health sciences ,ddc:618 ,Cerebellar Diseases/diagnosis/genetics ,Kidney Diseases, Cystic ,Pedigree ,3. Good health ,Phenotype ,Child, Preschool ,Medical genetics ,Female ,Retinitis Pigmentosa ,FORM ,Ciliary Motility Disorders ,Heterozygote ,medicine.medical_specialty ,2716 Genetics (clinical) ,Adolescent ,Molecular Sequence Data ,Encephalocele/diagnosis/genetics ,AHI1 ,610 Medicine & health ,Biology ,Retina ,Article ,Ciliopathies, INPP5E, Joubert syndrome and related disorders, Meckel syndrome ,NO ,Ciliary Motility Disorders/diagnosis/genetics ,03 medical and health sciences ,1311 Genetics ,Cerebellar Diseases ,REVEALS ,medicine ,Humans ,Abnormalities, Multiple ,Amino Acid Sequence ,Kidney Diseases, Cystic/diagnosis/genetics ,abnormalities ,multiple ,adolescent ,amino acid sequence ,cerebellar diseases ,cerebellum ,child ,preschool ,ciliary motility disorders ,encephalocele ,eye abnormalities ,female ,heterozygote ,humans ,infant ,kidney diseases, cystic ,male ,molecular sequence data ,pedigree ,phosphoric monoester hydrolases ,polycystic kidney diseases ,prenatal diagnosis ,prevalence ,retina ,gene frequency ,mutation ,phenotype ,030304 developmental biology ,Eye Abnormalities/diagnosis/genetics ,COACH SYNDROME ,Retina/abnormalities ,Genetic heterogeneity ,Respiration disorders -- Therapy ,Infant ,medicine.disease ,Phosphoric Monoester Hydrolases ,INPP5E mutation ,10036 Medical Clinic ,Mutation ,030217 neurology & neurosurgery - Abstract
Joubert syndrome and related disorders (JSRD) are clinically and genetically heterogeneous ciliopathies sharing a peculiar midbrain–hindbrain malformation known as the ‘molar tooth sign’. To date, 19 causative genes have been identified, all coding for proteins of the primary cilium. There is clinical and genetic overlap with other ciliopathies, in particular with Meckel syndrome (MKS), that is allelic to JSRD at nine distinct loci. We previously identified the INPP5E gene as causative of JSRD in seven families linked to the JBTS1 locus, yet the phenotypic spectrum and prevalence of INPP5E mutations in JSRD and MKS remain largely unknown. To address this issue, we performed INPP5E mutation analysis in 483 probands, including 408 JSRD patients representative of all clinical subgroups and 75 MKS fetuses. We identified 12 different mutations in 17 probands from 11 JSRD families, with an overall 2.7% mutation frequency among JSRD. The most common clinical presentation among mutated families (7/11, 64%) was Joubert syndrome with ocular involvement (either progressive retinopathy and/or colobomas), while the remaining cases had pure JS. Kidney, liver and skeletal involvement were not observed. None of the MKS foetuses carried INPP5E mutations, indicating that the two ciliopathies are not allelic at this locus., peer-reviewed
- Published
- 2013
53. The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome
- Author
-
Sailani, M.R. Makrythanasis, P. Valsesia, A. Santoni, F.A. Deutsch, S. Popadin, K. Borel, C. Migliavacca, E. Sharp, A.J. Sail, G.D. Falconnet, E. Rabionet, K. Serra-Juhé, C. Vicari, S. Laux, D. Grattau, Y. Dembour, G. Megarbane, A. Touraine, R. Stora, S. Kitsiou, S. Fryssira, H. Chatzisevastou-Loukidou, C. Kanavakis, E. Merla, G. Bonnet, D. Pérez-Jurado, L.A. Estivill, X. Delabar, J.M. Antonarakis, S.E.
- Subjects
cardiovascular diseases - Abstract
Congenital heart defect (CHD) occurs in 40% of Down syndrome (DS) cases. While carrying three copies of chromosome 21 increases the risk for CHD, trisomy 21 itself is not sufficient to cause CHD. Thus, additional genetic variation and/or environmental factors could contribute to the CHD risk. Here we report genomic variations that in oncert with trisomy 21, determine the risk for CHD in DS. This case-control GWAS includes 187 DS with CHD (AVSD = 69, ASD = 53, VSD = 65) as cases, and 151 DS without CHD as controls. Chromosome 21-specific association studies revealed rs2832616 and rs1943950 as CHD risk alleles (adjusted genotypic P-values < 0.05). These signals were confirmed in a replication cohort of 92 DS-CHD cases and 80 DS-without CHD (nominal P-value 0.0022). Furthermore, CNV analyses using a customized chromosome 21 aCGH of 135K probes in 55 DS-AVSD and 53 DS-without CHD revealed three CNV regions associated with AVSD risk (FDR ≤ 0.05). Two of these regions that are located within the previously identified CHD region on chromosome 21 were further confirmed in a replication study of 49 DS-AVSD and 45 DS- without CHD (FDR ≤ 0.05). One of these CNVs maps near the RIPK4 gene, and the second includes the ZBTB21 (previously ZNF295) gene, highlighting the potential role of these genes in the pathogenesis of CHD in DS. We propose that the genetic architecture of the CHD risk of DS is complex and includes trisomy 21, and SNP and CNV variations in chromosome 21. In addition, a yetunidentified genetic variation in the rest of the genome may contribute to this complex genetic architecture. © 2013, Published by Cold Spring Harbor Laboratory Press.
- Published
- 2013
54. VIIℴ journées de diabétologie de l'Hôtel-Dieu extraits
- Author
-
Jeanrenaud, B., Balasse, E., Gepts, W., de L'hortet, G. Collin, Swynghedauw, B., de Gennes, J. L., Truffert, J., Duhault, J., Boulanger, M., Derot, M., Rathery, M., Lamotte, M., Segrestaa, J. M., degos, R., Touraine, R., Civatte, J., Cottenot, F., de Graciansky, P., Ledoux-Lebard, G., Heitz, F., Rosier, J., Behar, A., Atlan, H., Fröberg, S., Power, L., Fankkhauser, S., Felber, J. P., Magyar, I., R-Candela, J. L., Coppo, M., Di Marco, Beurey, J., Jeandidier, P., Bermont, A., Barenghi, G., and Chaia, J.
- Published
- 1966
- Full Text
- View/download PDF
55. Explication génétique d’une ancienne entité clinique : angiokératome de Mibelli
- Author
-
Cinotti, E., primary, Perrot, J.L., additional, Labeille, B., additional, Touraine, R., additional, Antoine, J.C., additional, and Cambazard, F., additional
- Published
- 2014
- Full Text
- View/download PDF
56. MKS3/TMEM67 mutations are a major cause of COACH Syndrome, a Joubert Syndrome related disorder with liver involvement
- Author
-
Brancati, F., Iannicelli, M., Travaglini, L., Mazzotta, A., Bertini, E., Boltshauser, E., D?arrigo, S., Emma, F., Fazzi, E., Gallizzi, R., Gentile, M., Loncarevic, D., Mejaski-Bosnjak, V., Pantaleoni, C., Rigoli, L., Salpietro, C. D., Signorini, S., Stringini, G. R., Verloes, A., Zabloka, D., Dallapiccola, B., Gleeson, J. G., Valente, E. M., Zankl, A., Leventer, R., Smith, P. G., Janecke, A., D?hooghe, M., Sznajer, Y., Van Coster, R., Demerleir, L., Dias, K., Moco, C., Moreira, A., Ae Kim, C., Maegawa, G., Petkovic, D., Abdel-Salam, G. M. H., Abdel-Aleem, A., Zaki, M. S., Marti, I., Quijano-Roy, S., Sigaudy, S., De Lonlay, P., Romano, S., Touraine, R., Koenig, M., Lagier-Tourenne, C., Messer, J., Collignon, P., Wolf, N., Philippi, H., Tzeli, S. K., Halldorsson, S., Johannsdottir, J., Ludvigsson, P., Phadke, S. R., Udani, V., Stuart, B., Magee, A., Lev, D., Michelson, M., Ben-Zeev, B., Fischetto, R., Benedicenti, F., Stanzial, F., Borgatti, R., Accorsi, P., Battaglia, S., Giordano, L., Pinelli, L., Boccone, L., Bigoni, S., Ferlini, A., Donati, M. A., Caridi, G., Divizia, M. T., Faravelli, F., Ghiggeri, G., Pessagno, A., Briuglia, S., Tortorella, G., Adami, A., Castorina, P., Lalatta, F., Marra, G., Riva, D., Scelsa, B., Spaccini, L., Uziel, G., Giudice, E. D., Laverda, A. M., Ludwig, K., Permunian, A., Suppiej, A., Uggetti, C., Battini, R., Giacomo, M. D., Cilio, M. R., Di Sabato, M. L., Leuzzi, V., Parisi, P., Pollazzon, M., Silengo, M., De Vescovi, R., Greco, D., Romano, C., Cazzagon, M., Simonati, A., Al-Tawari, A. A., Bastaki, L., M('e)garban('e), A., Sabolic Avramovska, V., De Jong, M. M., Stromme, P., Koul, R., Rajab, A., Azam, M., Barbot, C., Martorell Sampol, L., Rodriguez, B., Pascual-Castroviejo, I., Teber, S., Anlar, B., Comu, S., Karaca, E., Kayserili, H., Y, Brancati, F, Iannicelli, M, Travaglini, L, Mazzotta, A, Bertini, E, Boltshauser, E, D'Arrigo, S, Emma, F, Fazzi, E, Gallizzi, R, Gentile, M, Loncarevic, D, Mejaski Bosnjak, V, Pantaleoni, C, Rigoli, L, Salpietro, Cd, Signorini, S, Stringini, Gr, Verloes, A, Zabloka, D, Dallapiccola, B, Gleeson, Jg, Valente, Em, International, JSRD Study Group, DEL GIUDICE, Ennio, and Pediatric surgery
- Subjects
Pathology ,medicine.medical_specialty ,TMEM67 ,DNA Mutational Analysis ,Molecular Sequence Data ,education ,Biology ,Article ,Joubert syndrome ,NO ,MKS3 ,COACH ,Multiple Abnormalities ,Nephronophthisis ,Amino Acid Sequence ,Base Sequence ,Humans ,Liver ,Magnetic Resonance Imaging ,Membrane Proteins ,Mutation ,Phenotype ,RNA Splice Sites ,Syndrome ,Genetics ,medicine ,congenital hepatic fibrosis ,Abnormalities, Multiple ,Meckel syndrome ,COACH syndrome ,Joubert syndrome and related disorders ,Genetics (clinical) ,Aplasia ,medicine.disease ,MKS3/TMEM67 mutation ,COACH Syndrome ,Ciliopathy ,RPGRIP1L ,Congenital hepatic fibrosis ,human activities - Abstract
MKS3/TMEM67 mutations are a major cause of COACH Syndrome, a Joubert syndrome related disorder with liver involvement. The acronym COACH defines an autosomal recessive condition of Cerebellar vermis hypo/aplasia, Oligophrenia, congenital Ataxia, Coloboma and Hepatic fibrosis. Patients present the molar tooth sign, a midbrain-hindbrain malformation pathognomonic for Joubert Syndrome (JS) and Related Disorders (JSRDs). The main feature of COACH is congenital hepatic fibrosis (CHF), resulting from malformation of the embryonic ductal plate. CHF is invariably found also in Meckel syndrome (MS), a lethal ciliopathy already found to be allelic with JSRDs at the CEP290 and RPGRIP1L genes. Recently, mutations in the MKS3 gene (approved symbol TMEM67), causative of about 7% MS cases, have been detected in few Meckel-like and pure JS patients. Analysis of MKS3 in 14 COACH families identified mutations in 8 (57%). Features such as colobomas and nephronophthisis were found only in a subset of mutated cases. These data confirm COACH as a distinct JSRD subgroup with core features of JS plus CHF, which major gene is MKS3, and further strengthen gene-phenotype correlates in JSRDs.
- Published
- 2009
57. Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndrome
- Author
-
Cantagrel, V, Silhavy, Jl, Bielas, S, Swistun, D, Marsh, Se, Bertrand, J, Audollent, S, Attié Bitach, T, Holden, Kr, Dobyns, Wb, Traver, D, Al Gazali, L, Ali, Br, Lindner, Th, Caspary, T, Otto, Ea, Hildebrandt, F, Glass, Ia, Logan, Cv, Johnson, Ca, Bennett, C, Brancati, F, Grattan Smith, P, Leventer, J, Van Coster, R, Dias, K, Moco, C, Moreira, Ae Kim, C, Akiss, A, Maegawa, G, Abdel Salam GMH, Abdel Aleem, A, Zaki, Ms, Marti, I, Quijano Roy, S, de Lonlay, P, Verloes A, A., Touraine, R, Koenig, M, Lagier Tourenne, C, Messer, J, Philippi, H, Tzeli, Sk, Halldorsson, S, Johannsdottir, J, Ludvigsson, P, Magee, A, Stuart, B, Lev, D, Michelson, M, Ben Zeev, B, Fischetto, R, Gentile, M, Battaglia, Giordano, L, Boccone, L, Ruggieri, M, Bigoni, S, Ferlini, A, Donati, Ma, Procopio, E, Lapi, E, Genuardi, M, Caridi, G, Faravelli, F, Ghiggeri, G, Briuglia, Silvana, Tortorella, Gaetano, Rigoli, Luciana Concetta, SALPIETRO DAMIANO, Carmelo, D’Arrigo, S, Pantaleoni, C, Riva, D, Uziel, G, Laverda, Am, Permunian, A, Bova, S, Fazz, Ei, Sabrina, S, Battini, R, Bertini, E, Dallapiccola, B, Cilio, Mr, Di Sabato, M, Emma, F, Leuzzi, V, Parisi, P, Simonati, A, Al Tawari AA, Bastaki, L, Ahmad Aqueel, A, Jong, Mm, Koul, R, Rajab, A, Sztriha, L, Azam, M, Barbot, C, Rodriguez, B, Pascual Castroviejo, I, Eugen Boltshauser, E, Hulya, H, Comu, S, Akcakus, M, Sahin, Y, Phadke, Sr, Melick, N, Mikati, M, Nicholl, D, Hurst, J, Hennekam, Rcm, Bernes, S, Sanchez, H, Clark, Ae, Wynshaw Boris, A, Donahue, C, Sherr, Eh, Barkovich, Aj, Hahn, D., Sanger, Td, Gallager, Te, Daugherty, C, Krishnamoorthy, Ks, Sarco, D, Walsh CA, Soul, Jmckanna, T, Joanne Milisa, J, Chung, Wk, De Vivo DC, Raynes, H, Schubert, R, Seward, A, Brooks, Dg, Amy Goldstein, A, Caldwell, J, Finsecke, E, Maria, Bl, Cruse, Rp, Lotzete, Swoboda, Kj, Viskochil, Dh, Valente, Em, Woods, Cg, and Gleeson, Jg
- Subjects
Cerebellum ,Ataxia ,TMEM67 ,Molecular Sequence Data ,Biology ,Joubert Syndrome ,Joubert syndrome ,Article ,cilia gene ARL13B ,mutation ,03 medical and health sciences ,0302 clinical medicine ,Ciliogenesis ,INPP5E ,medicine ,Genetics ,Animals ,Humans ,Genetics(clinical) ,Abnormalities, Multiple ,Genetic Predisposition to Disease ,Cilia ,Genetics (clinical) ,Conserved Sequence ,Zebrafish ,030304 developmental biology ,Neurons ,0303 health sciences ,Brain Diseases ,ADP-Ribosylation Factors ,Cilium ,Chromosome Mapping ,Computational Biology ,Syndrome ,Mutation ,medicine.disease ,Cell biology ,medicine.anatomical_structure ,RPGRIP1L ,medicine.symptom ,Abnormalities ,Multiple ,030217 neurology & neurosurgery - Abstract
Joubert syndrome (JS) and related disorders are a group of autosomal-recessive conditions sharing the “molar tooth sign” on axial brain MRI, together with cerebellar vermis hypoplasia, ataxia, and psychomotor delay. JS is suggested to be a disorder of cilia function and is part of a spectrum of disorders involving retinal, renal, digital, oral, hepatic, and cerebral organs. We identified mutations in ARL13B in two families with the classical form of JS. ARL13B belongs to the Ras GTPase family, and in other species is required for ciliogenesis, body axis formation, and renal function. The encoded Arl13b protein was expressed in developing murine cerebellum and localized to the cilia in primary neurons. Overexpression of human wild-type but not patient mutant ARL13B rescued the Arl13b scorpion zebrafish mutant. Thus, ARL13B has an evolutionarily conserved role mediating cilia function in multiple organs.
- Published
- 2008
58. CEP290 mutations are frequently identified in the oculo-renal form of Joubert syndrome-related disorders
- Author
-
Brancati, F., Barrano, G., Silhavy, J. L., Marsh, S. E., Travaglini, L., Bielas, S. L., Amorini, M., Zablocka, D., Kayserili, H., Al-Gazali, L., Bertini, E., Boltshauser, E., D'Hooghe, M., Fazzi, Eleonora, Fenerci, E. Y., Hennekam, R. C. M., Kiss, A., Lees, M. M., Marco, E., Phadke, S. R., Rigoli, L., Romano, S., Salpietro, C. D., Sherr, E. H., Signorini, S., Stromme, P., Stuart, B., Sztriha, L., Viskochil, D. H., Yuksel, A., Dallapiccola, B., Valente, E. M., Gleeson, J. G., Grattan-Smith, P., Leventer, R., Janecke, A., Van Coster, R., Dias, K., Moco, C., MOREIRA DA SILVA, CLAUDIA ALEXANDRA, Chong, A. K., Maegawa, G., Abdel-Salam, G. M. H., Abdel-Aleem, A., Zaki, M. S., Marti, I., Quijano-Roy, S., De Lonlay, P., Verloes, A., Touraine, R., Koenig, M., Lagier-Tourenne, C., Messer, J., Philippi, H., Tzeli, S. K., Halldorsson, S., Johannsdottir, J., Ludvigsson, P., Magee, A., Lev, D., Michelson, M., Ben-Zeev, B., Fischetto, R., Gentile, M., Battaglia, S., Giordano, L., Boccone, L., Ruggieri, M., Bigoni, S., Ferlini, A., Donati, M. A., Procopio, E., Caridi, G., Faravelli, F., Ghiggeri, G., Briuglia, S., Tortorella, G., D'Arrigo, S., Pantaleoni, C., Riva, D., Uziel, G., Lavercla, A. M., Permunian, A., Bova, S., Battini, Roberta, Cilio, M. R., DI SABATO, Manuela, Emma, F., Leuzzi, V., Parisi, P., Simonati, A., Al-Tawari, A. A., Bastaki, L., Aqeel, A., De Jong, M. M., Koul, R., Rajab, A., Azam, M., Barbot, C., Rodriguez, B., Pascual-Castroviejo, I., Comu, S., Akcakus, M., Nicholl, D., Woods, C. G., Bennett, C., Hurst, J., Walsh, C. A., Bernes, S., Sanchez, H., Clark, A. E., Donahue, C., Hahn, J., Sanger, T. D., Gallager, T. E., Dobyns, W. B., Daugherty, C., Krishnamoorthy, K. S., Sarco, D., Mckanna, T., Milisa, J., Chung, W. K., De Vivo, D. C., Raynes, H., Schubert, R., Seward, A., Brooks, D. G., Goldstein, A., Caldwell, J., Finsecke, E., Maria, B. L., Holden, K., Cruse, R. P., Swoboda, K. J., ANS - Amsterdam Neuroscience, APH - Amsterdam Public Health, and Paediatric Genetics
- Subjects
Male ,Pathology ,DNA Mutational Analysis ,Cell Cycle Proteins ,medicine.disease_cause ,Ciliopathies ,Ocular Motility Disorders ,Cohort Studies ,Joubert syndrome–related disorders ,CEP290 ,Genetics(clinical) ,Child ,Genetics (clinical) ,Genetics ,Mutation ,Brain ,Syndrome ,Phenotype ,Magnetic Resonance Imaging ,Kidney Diseases ,Molar ,Neoplasm Proteins ,Child, Preschool ,Abnormalities, Multiple ,Adolescent ,Adult ,Antigens, Neoplasm ,Female ,Humans ,Abnormalities ,Multiple ,medicine.medical_specialty ,Biology ,Article ,Joubert syndrome ,Central nervous system disease ,medicine ,Antigens ,Preschool ,Genetic heterogeneity ,medicine.disease ,Cytoskeletal Proteins ,Situs inversus ,Neoplasm - Abstract
Joubert syndrome–related disorders (JSRDs) are a group of clinically and genetically heterogeneous conditions that share a midbrain-hindbrain malformation, the molar tooth sign (MTS) visible on brain imaging, with variable neurological, ocular, and renal manifestations. Mutations in the CEP290 gene were recently identified in families with the MTS-related neurological features, many of which showed oculo-renal involvement typical of Senior-Löken syndrome (JSRD-SLS phenotype). Here, we performed comprehensive CEP290-mutation analysis on two nonoverlapping cohorts of JSRD-affected patients with a proven MTS. We identified mutations in 19 of 44 patients with JSRD-SLS. The second cohort consisted of 84 patients representing the spectrum of other JSRD subtypes, with mutations identified in only two patients. The data suggest that CEP290 mutations are frequently encountered and are largely specific to the JSRD-SLS subtype. One patient with mutation displayed complete situs inversus, confirming the clinical and genetic overlap between JSRDs and other ciliopathies.
- Published
- 2007
59. CEP290 mutations are frequently identified in the oculo-renal form of Joubert syndrome-related disorders
- Author
-
Brancati, F, Barrano, G, Silhavy, Jl, Marsh, Se, Travaglini, L, Bielas, Sl, Amorini, M, Zablocka, D, Kayserili, H, Al Gazali, L, Bertini, E, Boltshauser, E, D'Hooghe, M, Fazzi, E, Fenerci, Ey, Hennekam, Rc, Kiss, A, Lees, Mm, Marco, E, Phadke, Sr, Rigoli, L, Romano, S, Salpietro, Cd, Sherr, Eh, Signorini, S, Stromme, P, Stuart, B, Sztriha, L, Viskochil, Dh, Yuksel, A, Dallapiccola, [International JSRD Study Group], Valente, Em, Gleeson, Jg, Smith, P, Leventer, R, Janecke, A, Van Coster, R, Dias, K, Moco, C, Moreira, A, Chong, Ak, Maegawa, G, Abdel Salam GMH, Abdel Aleem, A, Zaki, Ms, Martu, I, Quijano Roy, S, De Lonlay, P, Verloes, A, Touraine, R, Koenig, M, Lagier Tourenne, C, Messer, J, Philippi, H, Tzeli, Sk, Halldorsson, S, Johannsdotir, J, Ludvigsson, P, Magee, A, Lev, D, Michelson, M, Ben Zev, B, Fischetto, R, Gentile, M, Battaglia, S, Giordano, L, Boccone, L, Ruggieri, Martino, Bigoni, S, Ferlini, A, Donati, Ma, Procopio, E, Cardidi, G, Faravelli, F, Ghiggeri, G, Briuglia, S, Tortorella, G, D’Arrigo, S, Pantaleoni, C, Riva, D, Uziel, G, Lavercla, Am, Permunian, A, Bova, S, Battini, R, Cilio, Mr, Di Sabato, M, Emma, F, Leuzzi, V, Parisi, P, Simonati, A, Al Tawari AA, Bastaki, L, Aqeel, A, De Jong MM, Koul, R, Rajab, A, Azam, M, Barbot, C, Rodriguez, B, Pascual Castroviejo, I, Comu, S, Akcakus, M, Nicholl, D, Woods, Cg, Bennet, C, Hurst, J, Walsh, Ca, Bernes, S, Sanchez, H, Clark, Ae, Donahue, C, Hahn, J, Sanger, Td, Gallager, Te, Dobyns, Wb, Daugherty, C, Krishnamoorthy, Ks, Sarco, D, Mckanna, T, Milisa, J, Chung, Wk, De Vivo DC, Raynes, H, Schubert, R, Seward, A, Brooks, Dg, Goldstein, A, Caldwell, J, Finsecke, E, Maria, Bl, Holden, K, Cruse, Rp, and Swoboda, Kj
- Published
- 2007
60. Contributors
- Author
-
Ahmed, A.R., primary, Allen, M.H., additional, Amlot, P.L., additional, Archer, C.B., additional, Ayala, F., additional, Anne Bach, Marie, additional, Baker, B.S., additional, Berger, C., additional, Berti, E., additional, Bhogal, B., additional, Bjerke, J.R., additional, Black, M.M., additional, Bonifazi, E., additional, Bork, K., additional, Bos, J.D., additional, Botham, P.A., additional, Bourland, A., additional, Braun-Falco, O., additional, Brochier, J., additional, Bröcker, Eva-B., additional, Brüggen, J., additional, Buck, B.E., additional, Budillon, G., additional, Burg, G., additional, Burnham, T.K., additional, Camarasa, J.G., additional, Caputo, R., additional, Carr, M.M., additional, Cats, A., additional, Cavicchini, S., additional, Chapman, D.V., additional, Christophers, E., additional, Claudatus, J.C., additional, Cordier, G., additional, Cottenot, F., additional, Cramers, Marie, additional, Cuomo, R., additional, Cusini, M., additional, Czarnetzki, Beate M., additional, Czernielewski, J., additional, Daha, M.R., additional, De Jong, M.C.J.M., additional, Del Prete, G.F., additional, Demarchez, M., additional, De Nijs, J.A.M., additional, De Panfilis, G., additional, Detmar, U., additional, Dezutter-Dambuyant, C., additional, Djawari, D., additional, Donhuijsen, K., additional, Dubertret, L., additional, Edelson, R., additional, Ely, H., additional, Emsbroek, J.A., additional, Fattorossi, A., additional, Faure, M., additional, Flageul, Beatrice, additional, Fosse, M., additional, Frappez, A., additional, Freytag, W., additional, Fry, L., additional, Garcia Calderón, P., additional, Gaucherand, M., additional, Gawkrodger, D.J., additional, Gebhart, W., additional, Giannotti, B., additional, Grabbe, J., additional, Graham, R.M., additional, Gretenkord, B., additional, Hauck, H., additional, Haneke, E., additional, Happle, R., additional, Harber, L.C., additional, Heinzerling, R.H., additional, Herlin, T., additional, Heyderman, E., additional, Hobbs, Suzanne, additional, Holborow, E.J., additional, Holden, C.A., additional, Holmes, R.C., additional, Horton, J.J., additional, Hunter, J.A.A., additional, Hutterer, J., additional, Isaacson, P.G., additional, Ishikawa, H., additional, Ishikawa, O., additional, James, D.C.O., additional, Jensen, J., additional, Jung, Michaela, additional, Kanerva, L., additional, Kariniemi, Arja-Leena, additional, Kaudewitz, P., additional, Kemeny, D.M., additional, Kind, P., additional, Kleinsmith, D'Anne M., additional, Knop, J., additional, Kohda, M., additional, Blumenkranz, Recia Kott, additional, Kraft, D., additional, Kragballe, K., additional, Krieg, S.R., additional, Krogh, H.K., additional, Lachapelle, J.M., additional, Laquoi, C., additional, Lassmann, H., additional, Lauharanta, J., additional, Leder, L.-D., additional, Leibl, H., additional, Lembo, G., additional, Leonard, J.N., additional, Lessof, M.H., additional, Linder, E., additional, McCarthy, D.A., additional, Macher, E., additional, McKee, P.H., additional, McVittie, E., additional, Mardin, M., additional, Marsden, R.A., additional, Mason, D.Y., additional, Matre, R., additional, Meijer, C.J.L.M., additional, Meneghini, C.L., additional, Monti, M., additional, Morley, J., additional, Moretti, S., additional, Morsches, B., additional, Mynttinen, S., additional, Nadji, M., additional, Niemi, Kirsti-Maria, additional, Norris, D.A., additional, Page, C.P., additional, Paindelli, M.G., additional, Palermo, A., additional, Parkes, P.E., additional, Parolini, F., additional, Parrilli, G., additional, Pelachyk, J.M., additional, Penneys, N.S., additional, Perret, Ch., additional, Pihlman, K., additional, Plosila, M., additional, Poulter, L.W., additional, Powell, F.C., additional, Prost, C., additional, Prunieras, M., additional, Ranki, Annamari, additional, Rantala, I., additional, Reunala, T., additional, Richardson, T.C., additional, Rieber, P., additional, Romani, N., additional, Ross, J.A., additional, Ruiter, D.J., additional, Rumpold, H., additional, Russell-Jones, R., additional, Santoianni, P., additional, Santucci, M., additional, Scheffer, E., additional, Schlaak, H.-E., additional, Schmitt, D., additional, Schopf, R.E., additional, Schrenker, T., additional, Schröder, J.-M., additional, Schroeter, A.L., additional, Schubert, Ch., additional, Schuler, G., additional, Schuller-Petrovic, S., additional, Serri, R., additional, Simon, M., additional, Smith, N.P., additional, Sorg, C., additional, Spaull, J., additional, Staquet, M.J., additional, Stewart, I.C., additional, Stingl, G., additional, Stubb, S., additional, Suter, L., additional, Swain, A.F., additional, Taborsky, U., additional, Tamura, T., additional, Ternowitz, S., additional, Thestrup-Pedersen, K., additional, Thivolet, J., additional, Touraine, R., additional, Tschachler, E., additional, Tuffanelli, D., additional, Unsworth, D.J., additional, Valdimarsson, Helgi, additional, Van der Meer, J.B., additional, van Vloten, W.A., additional, Vermeer, B.J., additional, Vesterinen, E., additional, Viac, J., additional, Villa, A., additional, Wahlström, T., additional, Wallach, D., additional, Westedt, M.L., additional, Wiesner-Menzel, L., additional, Willemze, R., additional, Wojnarowska, Fenella, additional, Wolff, K., additional, Zachariae, H., additional, and Zachary, C.B., additional
- Published
- 1984
- Full Text
- View/download PDF
61. Immunocytochemistry at the electron microscopic level: a new routine technique
- Author
-
Dubertret, L., primary, Prost, C., additional, Fosse, M., additional, and Touraine, R., additional
- Published
- 1984
- Full Text
- View/download PDF
62. Genetic susceptibility towards NSAID-induced toxic epidermal necrolysis
- Author
-
Roujeau, J.-C., primary, Guillaume, J.-C., additional, Bracq, C., additional, Revuz, J., additional, and Touraine, R., additional
- Published
- 1987
- Full Text
- View/download PDF
63. Les atrophies cutanées au cours de la corticothérapie générale
- Author
-
Touraine, R., primary, Fournet, M., additional, and Belaïch, S., additional
- Published
- 1968
- Full Text
- View/download PDF
64. Xq28 duplication including MECP2 in six unreported affected females: what can we learn for diagnosis and genetic counselling?
- Author
-
El Chehadeh, S., Touraine, R., Prieur, F., Reardon, W., Bienvenu, T., Chantot ‐ Bastaraud, S., Doco ‐ Fenzy, M., Landais, E., Philippe, C., Marle, N., Callier, P., Mosca ‐ Boidron, A. ‐ L., Mugneret, F., Le Meur, N., Goldenberg, A., Guerrot, A. ‐ M., Chambon, P., Satre, V., Coutton, C., and Jouk, P. ‐ S.
- Subjects
- *
X chromosome , *GENETIC correlations , *PHENOTYPES , *SPASTICITY , *EPILEPSY - Abstract
Duplication of the Xq28 region, involving MECP2 (dupMECP2), has been primarily described in males with severe developmental delay, spasticity, epilepsy, stereotyped movements and recurrent infections. Carrier mothers are usually asymptomatic with an extremely skewed X chromosome inactivation (XCI) pattern. We report a series of six novel symptomatic females carrying a de novo interstitial dupMECP2, and review the 14 symptomatic females reported to date, with the aim to further delineate their phenotype and give clues for genetic counselling. One patient was adopted and among the other 19 patients, seven (37%) had inherited their duplication from their mother, including three mildly (XCI: 70/30, 63/37, 100/0 in blood and random in saliva), one moderately (XCI: random) and three severely (XCI: uninformative and 88/12) affected patients. After combining our data with data from the literature, we could not show a correlation between XCI in the blood or duplication size and the severity of the phenotype, or explain the presence of a phenotype in these females. These findings confirm that an abnormal phenotype, even severe, can be a rare event in females born to asymptomatic carrier mothers, making genetic counselling difficult in couples at risk in terms of prognosis, in particular in prenatal cases. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
65. Étude de corrélation génotype-phénotype chez des patients avec réarrangement de la région du gène SHOX détecté par MLPA dans la population française
- Author
-
Auger, J., primary, Baptiste, A., additional, Schmitt, S., additional, Thierry, G., additional, Costa, J.M., additional, Amouyal, M., additional, Kottler, M.L., additional, Touraine, R., additional, Lebru, M., additional, Leheup, B., additional, Cormier-Daire, V., additional, De Roux, N., additional, Elie, C., additional, and Bonnefont, J.P., additional
- Published
- 2014
- Full Text
- View/download PDF
66. Health-related quality of life of people with down’s syndrome: Initial results from a non-drug longitudinal multi-nationl study
- Author
-
Rofail, D., primary, De La Torre, R., additional, Dorison, N., additional, Edgin, J., additional, Kishnani, P., additional, Touraine, R., additional, Whitwham, S., additional, Squassante, L., additional, Liogier D’Ardhuy, X., additional, and Khwaja, O., additional
- Published
- 2014
- Full Text
- View/download PDF
67. Localization of a non-syndromic X-linked mental retardation gene (MRX80) to Xq22-q24
- Author
-
Verot, L., Alloisio, N., Morle, L., Bozon, M., Touraine, R., Plauchu, H., Ederly, P., and Laviron, Nathalie
- Subjects
[SDV.BC] Life Sciences [q-bio]/Cellular Biology - Published
- 2003
68. BDNF and DYRK1A are variable and inversely correlated in lymphoblastoid cell lines from Down syndrome patients
- Author
-
Tlili, A., Hoischen, A., Ripoll, C., Benabou, E., Badel, A., Ronan, A., Touraine, R., Grattau, Y., Stora, S., van Bon, B., de Vries, B., Menten, B., Bockaert, N., Gecz, J., Antonarakis, S.E., Campion, D., Potier, M.C., Blehaut, H., Delabar, J.M., Janel, N., Tlili, A., Hoischen, A., Ripoll, C., Benabou, E., Badel, A., Ronan, A., Touraine, R., Grattau, Y., Stora, S., van Bon, B., de Vries, B., Menten, B., Bockaert, N., Gecz, J., Antonarakis, S.E., Campion, D., Potier, M.C., Blehaut, H., Delabar, J.M., and Janel, N.
- Abstract
Item does not contain fulltext, Down syndrome or trisomy 21 is the most common genetic disorder leading to mental retardation. One feature is impaired short- and long-term spatial memory, which has been linked to altered brain-derived neurotrophic factor (BDNF) levels. Mouse models of Down syndrome have been used to assess neurotrophin levels, and reduced BDNF has been demonstrated in brains of adult transgenic mice overexpressing Dyrk1a, a candidate gene for Down syndrome phenotypes. Given the link between DYRK1A overexpression and BDNF reduction in mice, we sought to assess a similar association in humans with Down syndrome. To determine the effect of DYRK1A overexpression on BDNF in the genomic context of both complete trisomy 21 and partial trisomy 21, we used lymphoblastoid cell lines from patients with complete aneuploidy of human chromosome 21 (three copies of DYRK1A) and from patients with partial aneuploidy having either two or three copies of DYRK1A. Decreased BDNF levels were found in lymphoblastoid cell lines from individuals with complete aneuploidy as well as those with partial aneuploidies conferring three DYRK1A alleles. In contrast, lymphoblastoid cell lines from individuals with partial trisomy 21 having only two DYRK1A copies displayed increased BDNF levels. A negative correlation was also detected between BDNF and DYRK1A levels in lymphoblastoid cell lines with complete aneuploidy of human chromosome 21. This finding indicates an upward regulatory role of DYRK1A expression on BDNF levels in lymphoblastoid cell lines and emphasizes the role of genetic variants associated with psychiatric disorders.
- Published
- 2012
69. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2
- Author
-
Walters, RG, Jacquemont, S, Valsesia, A, de Smith, AJ, Martinet, D, Andersson, J, Falchi, M, Chen, F, Andrieux, J, Lobbens, S, Delobel, B, Stutzmann, F, Moustafa, JSE-S, Chevre, J-C, Lecoeur, C, Vatin, V, Bouquillon, S, Buxton, JL, Boute, O, Holder-Espinasse, M, Cuisset, J-M, Lemaitre, M-P, Ambresin, A-E, Brioschi, A, Gaillard, M, Giusti, V, Fellmann, F, Ferrarini, A, Hadjikhani, N, Campion, D, Guilmatre, A, Goldenberg, A, Calmels, N, Mandel, J-L, Le Caignec, C, David, A, Isidor, B, Cordier, M-P, Dupuis-Girod, S, Labalme, A, Sanlaville, D, Beri-Dexheimer, M, Jonveaux, P, Leheup, B, Ounap, K, Bochukova, EG, Henning, E, Keogh, J, Ellis, RJ, MacDermot, KD, van Haelst, MM, Vincent-Delorme, C, Plessis, G, Touraine, R, Philippe, A, Malan, V, Mathieu-Dramard, M, Chiesa, J, Blaumeiser, B, Kooy, RF, Caiazzo, R, Pigeyre, M, Balkau, B, Sladek, R, Bergmann, S, Mooser, V, Waterworth, D, Reymond, A, Vollenweider, P, Waeber, G, Kurg, A, Palta, P, Esko, T, Metspalu, A, Nelis, M, Elliott, P, Hartikainen, A-L, McCarthy, MI, Peltonen, L, Carlsson, L, Jacobson, P, Sjostrom, L, Huang, N, Hurles, ME, O'Rahilly, S, Farooqi, IS, Maennik, K, Jarvelin, M-R, Pattou, F, Meyre, D, Walley, AJ, Coin, LJM, Blakemore, AIF, Froguel, P, Beckmann, JS, Walters, RG, Jacquemont, S, Valsesia, A, de Smith, AJ, Martinet, D, Andersson, J, Falchi, M, Chen, F, Andrieux, J, Lobbens, S, Delobel, B, Stutzmann, F, Moustafa, JSE-S, Chevre, J-C, Lecoeur, C, Vatin, V, Bouquillon, S, Buxton, JL, Boute, O, Holder-Espinasse, M, Cuisset, J-M, Lemaitre, M-P, Ambresin, A-E, Brioschi, A, Gaillard, M, Giusti, V, Fellmann, F, Ferrarini, A, Hadjikhani, N, Campion, D, Guilmatre, A, Goldenberg, A, Calmels, N, Mandel, J-L, Le Caignec, C, David, A, Isidor, B, Cordier, M-P, Dupuis-Girod, S, Labalme, A, Sanlaville, D, Beri-Dexheimer, M, Jonveaux, P, Leheup, B, Ounap, K, Bochukova, EG, Henning, E, Keogh, J, Ellis, RJ, MacDermot, KD, van Haelst, MM, Vincent-Delorme, C, Plessis, G, Touraine, R, Philippe, A, Malan, V, Mathieu-Dramard, M, Chiesa, J, Blaumeiser, B, Kooy, RF, Caiazzo, R, Pigeyre, M, Balkau, B, Sladek, R, Bergmann, S, Mooser, V, Waterworth, D, Reymond, A, Vollenweider, P, Waeber, G, Kurg, A, Palta, P, Esko, T, Metspalu, A, Nelis, M, Elliott, P, Hartikainen, A-L, McCarthy, MI, Peltonen, L, Carlsson, L, Jacobson, P, Sjostrom, L, Huang, N, Hurles, ME, O'Rahilly, S, Farooqi, IS, Maennik, K, Jarvelin, M-R, Pattou, F, Meyre, D, Walley, AJ, Coin, LJM, Blakemore, AIF, Froguel, P, and Beckmann, JS
- Abstract
Obesity has become a major worldwide challenge to public health, owing to an interaction between the Western 'obesogenic' environment and a strong genetic contribution. Recent extensive genome-wide association studies (GWASs) have identified numerous single nucleotide polymorphisms associated with obesity, but these loci together account for only a small fraction of the known heritable component. Thus, the 'common disease, common variant' hypothesis is increasingly coming under challenge. Here we report a highly penetrant form of obesity, initially observed in 31 subjects who were heterozygous for deletions of at least 593 kilobases at 16p11.2 and whose ascertainment included cognitive deficits. Nineteen similar deletions were identified from GWAS data in 16,053 individuals from eight European cohorts. These deletions were absent from healthy non-obese controls and accounted for 0.7% of our morbid obesity cases (body mass index (BMI) >or= 40 kg m(-2) or BMI standard deviation score >or= 4; P = 6.4 x 10(-8), odds ratio 43.0), demonstrating the potential importance in common disease of rare variants with strong effects. This highlights a promising strategy for identifying missing heritability in obesity and other complex traits: cohorts with extreme phenotypes are likely to be enriched for rare variants, thereby improving power for their discovery. Subsequent analysis of the loci so identified may well reveal additional rare variants that further contribute to the missing heritability, as recently reported for SIM1 (ref. 3). The most productive approach may therefore be to combine the 'power of the extreme' in small, well-phenotyped cohorts, with targeted follow-up in case-control and population cohorts.
- Published
- 2010
70. Génotypage de polymorphismes génétiques responsables de la régulation de l’expression de CD40 ligand dans deux populations de donneurs de sang (Auvergne-Loire, France ; Sousse et Monastir, Tunisie)
- Author
-
Aloui, C., primary, Sut, C., additional, Fagan, J., additional, Prigent, A., additional, Cognasse, F., additional, Granados-Herbepin, V., additional, Touraine, R., additional, Hassine, M., additional, Chakroun, T., additional, Jemni-Yacoub, S., additional, Laradi, S., additional, and Garraud, O., additional
- Published
- 2013
- Full Text
- View/download PDF
71. Grossesse et syndrome d’Ehlers-Danlos vasculaire : prise en charge et complications
- Author
-
Dubruc, E., primary, Dupuis-Girod, S., additional, Khau Van Kien, P., additional, Denis-Belicard, E., additional, Chirossel, C., additional, Fokstuen, S., additional, Touraine, R., additional, and Plauchu, H., additional
- Published
- 2013
- Full Text
- View/download PDF
72. Syndrome de Börjeson-Forssman-Lehmann : phénotype et évolution clinique de la cohorte française
- Author
-
Marey, I., primary, Prieur, F., additional, Blesson, S., additional, Edery, P., additional, Roume, J., additional, Touraine, R., additional, Des Portes, V., additional, and Héron, D., additional
- Published
- 2013
- Full Text
- View/download PDF
73. OFD1mutations in males: phenotypic spectrum and ciliary basal body docking impairment
- Author
-
Thauvin-Robinet, C, primary, Thomas, S, additional, Sinico, M, additional, Aral, B, additional, Burglen, L, additional, Gigot, N, additional, Dollfus, H, additional, Rossignol, S, additional, Raynaud, M, additional, Philippe, C, additional, Badens, C, additional, Touraine, R, additional, Gomes, C, additional, Franco, B, additional, Lopez, E, additional, Elkhartoufi, N, additional, Faivre, L, additional, Munnich, A, additional, Boddaert, N, additional, Maldergem, L Van, additional, Encha-Razavi, F, additional, Lyonnet, S, additional, Vekemans, M, additional, Escudier, E, additional, and Attié-Bitach, T, additional
- Published
- 2012
- Full Text
- View/download PDF
74. Binder phenotype in mothers affected with autoimmune disorders
- Author
-
Colin, E., primary, Touraine, R., additional, Levaillant, J. M., additional, Pasquier, L., additional, Boussion, F., additional, Ferry, M., additional, Guichet, A., additional, Barth, M., additional, Mercier, A., additional, Gérard-Blanluet, M., additional, Odent, S., additional, and Bonneau, D., additional
- Published
- 2011
- Full Text
- View/download PDF
75. Neutrophil Studies in Psoriatics: In Vivo Migration, Phagocytosis and Bacterial Killing
- Author
-
Dubertret, L., Lebreton, C., and Touraine, R.
- Published
- 1982
76. The Renpenning syndrome spectrum: new clinical insights supported by 13 new PQBP1-mutated males
- Author
-
Germanaud, D, primary, Rossi, M, additional, Bussy, G, additional, Gérard, D, additional, Hertz-Pannier, L, additional, Blanchet, P, additional, Dollfus, H, additional, Giuliano, F, additional, Bennouna-Greene, V, additional, Sarda, P, additional, Sigaudy, S, additional, Curie, A, additional, Vincent, MC, additional, Touraine, R, additional, and des Portes, V, additional
- Published
- 2010
- Full Text
- View/download PDF
77. P309 - Le syndrome de Barth : à propos d’un cas
- Author
-
Walther-Louvier, U., primary, Schlegel, H., additional, Mercier, M., additional, Carneiro, M., additional, Echenne, B., additional, Voisin, M., additional, Chabrier, S., additional, Boyer, S., additional, Touraine, R., additional, and Rivier, F., additional
- Published
- 2010
- Full Text
- View/download PDF
78. Epistatic interactions with a common hypomorphicRET allele in syndromic Hirschsprung disease
- Author
-
de Pontual, L., primary, Pelet, A., additional, Clement-Ziza, M., additional, Trochet, D., additional, Antonarakis, S.E., additional, Attie-Bitach, T., additional, Beales, P.L., additional, Blouin, J.-L., additional, Dastot-Le Moal, F., additional, Dollfus, H., additional, Goossens, M., additional, Katsanis, N., additional, Touraine, R., additional, Feingold, J., additional, Munnich, A., additional, Lyonnet, S., additional, and Amiel, J., additional
- Published
- 2007
- Full Text
- View/download PDF
79. Graft versus host reaction and lichen planus
- Author
-
TOURAINE, R., primary, REVUZ, J., additional, DREYFUS, B., additional, ROCHANT, H., additional, and MANNONI, P., additional
- Published
- 2006
- Full Text
- View/download PDF
80. Study of folate in psoriasis: blood levels, intestinal absorption and cutaneous loss
- Author
-
TOURAINE, R., primary, REVUZ, J., additional, ZITTOUN, J., additional, JARRET, J., additional, and TULLIEZ, M., additional
- Published
- 2006
- Full Text
- View/download PDF
81. P160 - Syndrome de Rothmund-Thomson et déficit en hormone de croissance
- Author
-
Denis-Thely, L., primary, Bost, M., additional, Reymond, J.L., additional, Maitre, S., additional, Touraine, R., additional, and Cambazard, F., additional
- Published
- 2005
- Full Text
- View/download PDF
82. PMH72 - Health-related quality of life of people with down’s syndrome: Initial results from a non-drug longitudinal multi-nationl study
- Author
-
Rofail, D., De La Torre, R., Dorison, N., Edgin, J., Kishnani, P., Touraine, R., Whitwham, S., Squassante, L., Liogier D’Ardhuy, X., and Khwaja, O.
- Published
- 2014
- Full Text
- View/download PDF
83. Génétique moléculaire de la maladie de Hirschsprung : un modèle de neurocristopathie multigénique
- Author
-
Amiel, J., primary, Salomon, R., additional, Attié-Bitach, T., additional, Touraine, R., additional, Steffann, J., additional, Pelet, A., additional, Nihoul-Fékété, C., additional, Vekemans, M., additional, Munnich, A., additional, and Lyonnet, S., additional
- Published
- 2000
- Full Text
- View/download PDF
84. MR cholangiography in neonates and infants: feasibility and preliminary applications.
- Author
-
Guibaud, L, primary, Lachaud, A, additional, Touraine, R, additional, Guibal, A L, additional, Pelizzari, M, additional, Basset, T, additional, and Pracros, J P, additional
- Published
- 1998
- Full Text
- View/download PDF
85. GENE THERAPY
- Author
-
BLAESE, R. MICHAEL, primary, CULVER, K., additional, KOHN, D., additional, MORGAN, R., additional, MILLER, A D., additional, ANDERSON, W. F., additional, TOURAINE, R., additional, RAMSEY, W. J., additional, RAM, Z., additional, and OLDFIELD, E., additional
- Published
- 1996
- Full Text
- View/download PDF
86. Binder phenotype in mothers affected with autoimmune disorders.
- Author
-
Colin, E., Touraine, R., Levaillant, J. M., Pasquier, L., Boussion, F., Ferry, M., Guichet, A., Barth, M., Mercier, A., Gérard-Blanluet, M., Odent, S., and Bonneau, D.
- Subjects
- *
MATERNAL health , *AUTOIMMUNE diseases in women , *PHENOTYPES , *FETUS , *NASAL bone - Abstract
Objective: To report four foetal cases of the Binder phenotype associated with maternal autoimmune disorders. Patients and Methods: In three mothers with autoimmune diseases, 2D and 3D ultrasonographic measurements were made on four foetuses with the Binder profile, and were compared with postnatal phenotypes. Results: The Binder phenotype can be detected in early pregnancy (14.5 WG). All foetuses had verticalized nasal bones and midfacial hypoplasia. Punctuate calcifications were found in almost all the cases. No specific maternal auto-antibody has been associated with foetal Binder phenotype. Conclusion: Since the Binder phenotype can be diagnosed at ultrasound examination during pregnancy, it is important to establish the underlying cause so as to assess the foetal prognosis. This study stresses the importance of systematic checks for maternal autoimmune disease in cases of prenatally diagnosed Binder phenotypes. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
87. A simple, low-cost and non-invasive method for screening Y microdeletions in infertile men
- Author
-
Aknin-Seifer, I., Touraine, R.-L., Lejeune, H., Laurent, J.-L., Lauras, B., and Levy, R.
- Subjects
- *
Y chromosome , *SPERMATOGENESIS , *CELLS , *REPRODUCTION , *PATIENTS - Abstract
Objectives. – Recent investigations showed a high prevalence of Y chromosome microdeletions in men with severely impaired spermatogenesis. Screening for these men is recommended prior to assisted reproduction techniques. The aim of this study was to set up a simple method to detect Y deletion in infertile men. First, we tested the feasibility of cytobrush to collect oral cells as source of DNA. Second, we compared a classic PCR corresponding to European recommendations to the Promega kit®.Patients and methods . – Seventeen infertile male patients with previously characterized deletions were included in the present study, after fully informed written consent. Both oral cells and blood were used for DNA extraction. A specific DNA extraction protocol was carried out on the buccal cells. The DNAs were tested for Y deletion screening by two different methods.Results. – We retrieved between 4 and 10 μg of DNA per brush from buccal cells, allowing several multiplex PCR. The Promega kit® detected all the deletions but one: an AZFa deletion was not detected by the two markers of the kit covering this region. In addition, sY130, sY133 and SY153, included in the kit, are not reliable.Discussion and conclusions. – Buccal cells represent a convenient substitute for blood in testing for Y microdeletions. Both false negative and false positive results were obtained with Promega Kit®. On the opposite, PCR according to the European recommendations allow the accurate detection of Y microdeletion in our 17 cases, at a lower cost. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
88. The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication.
- Author
-
Touraine, R L, Ishii-Morita, H, Ramsey, W J, and Blaese, R M
- Subjects
- *
HERPES simplex virus , *THYMIDINE , *GANCICLOVIR , *GAP junctions (Cell biology) - Abstract
The bystander effect (BSE) is an interesting and important property of the herpes thymidine kinase/ganciclovir (hTK/GCV) system of gene therapy for cancer. With the BSE, not only are the hTK expressing cells killed upon ganciclovir (GCV) exposure but also neighboring wild-type tumor cells. On testing a large number of tumor cell lines in vitro, a wide range of sensitivity to bystander killing was found. Since transfer of toxic GCV metabolites from hTK-modified to wild-type tumor cells via gap junctions (GJ) seemed to be a likely mechanism of the BSE, we tested GJ function in these various tumors with a dye transfer technique and pharmacological agents known to affect GJ communication. We confirmed that mixtures of tumor cells resistant to the BSE did not show dye transfer from cell to cell while bystander-sensitive tumor cells did. Dieldrin, a drug known to decrease GJ communication, diminished dye transfer and also inhibited the BSE. Forskolin, an upregulator of cAMP did increase GJ, but directly inhibited hTK and therefore its effect on BSE could not be determined. We conclude that these observations further support the concept that functional GJ play an important role in the BSE and further suggest that pharmacological manipulation of GJ may influence the outcome of cancer therapy with hTK/GCV. [ABSTRACT FROM AUTHOR]
- Published
- 1998
- Full Text
- View/download PDF
89. Identification of fifteen novel mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in European patients with severe hypophosphatasia.
- Author
-
Mornet, E, Taillandier, A, Peyramaure, S, Kaper, F, Muller, F, Brenner, R, Bussière, P, Freisinger, P, Godard, J, Le Merrer, M, Oury, J F, Plauchu, H, Puddu, R, Rival, J M, Superti-Furga, A, Touraine, R L, Serre, J L, and Simon-Bouy, B
- Subjects
PHOSPHATASES ,HYPOPHOSPHATASIA ,GENETICS - Abstract
Hypophosphatasia is an inherited disorder characterised by defective bone mineralisation and deficiency of serum and tissue liver/bone/kidney alkaline phosphatase (L/B/K ALP) activity. We report the characterisation of tissue-nonspecific alkaline phosphatase (TNSALP) gene mutations in a series of 13 European families affected by perinatal, infantile or childhood hypophosphatasia. Eighteen distinct mutations were found, only three of which had been reported previously in North American and Japanese populations. Most of the 15 new mutations were missense mutations, but we also found two mutations affecting donor splice sites and a nonsense mutation. A missense mutation in the last codon of the putative signal peptide probably affects the final maturation of the protein. Despite extensive sequencing of the gene and its promotor region, only one mutation was identified in two cases, one of which was compatible with a possible dominant effect of certain mutations and the putative role of polymorphisms of the TNSALP gene. In 12 of the 13 tested families, genetic diagnosis was possible by characterisation of the mutations or by use of polymorphisms as genetic markers. Hypophosphatasia diagnosis was assigned in two families where clinical, laboratory and radiographic data were unclear and prenatal diagnosis was performed in one case. The results also show that severe hypophosphatasia is due to a very large spectrum of mutations in European populations with no prevalent mutation and that genetic diagnosis of the disease must be performed by extensive analysis of the gene. [ABSTRACT FROM AUTHOR]
- Published
- 1998
- Full Text
- View/download PDF
90. Correspondence.
- Author
-
Cox, N. H., Mitchell, J. N. S., Morley, W. N., Hussain, S .T., Evans, C. D., Wightman, J., Saiag, P., Coulomb, B., Rowland-Payne, C. M. E., Dubertret, L., Touraine, R., and Marks, Janet M.
- Subjects
LETTERS to the editor ,SKIN diseases ,PSORIASIS ,SKIN inflammation ,DOSAGE forms of drugs ,DERMATOLOGY - Abstract
Presents letters to the editor regarding articles published in the previous issues of the "British Journal of Dermatology." "Lichen sclerosus et atrophicus in non-identical female twins," which discusses the development of perineal lichen sclerosus et atrophicus in female twins; "Influence of containers on the quantities of topical preparations used," which was about the dispensing of topical agents; "Laser, dermal fibroblasts and psoriasis," which was about psoriasis.
- Published
- 1986
- Full Text
- View/download PDF
91. Maintenance treatment of psoriasis by Tigason: a double-blind randomized clinical trial.
- Author
-
Dubertret, L., Chastang, C., Beylot, C., Bazex, J., Rognin, C., and Touraine, R.
- Subjects
PSORIASIS ,DERMATOLOGIC agents ,CLINICAL trials ,ERYTHEMA ,CUTANEOUS manifestations of general diseases ,THERAPEUTICS ,SKIN diseases - Abstract
Extensive lesions on 36 patients with psoriasis were treated by Tigason, 1 mg kg/day plus PUVA until skin clearance. A clinical score was calculated for each body area, and erythema, scaling, thickness and pruritus of the lesions were scored from 0 to 3. Skin clearing was defined as a clinical score < 10% of the initial score. Double-blind maintenance treatment was then started. This was Tigason at half of the maximal dose tolerated during the clearing phase of the treatment v. placebo. Relapse of the disease was defined as the occurrence of a clinical score > 50% of the initial score. Among the 36 patients randomized, 20 received placebo and 16 received Tigason. Relapses increased quickly in the patients on placebo, but occurred in few patients treated by Tigason with 60% remaining clear after i year (P < 0.05). Surprisingly, the kinetics of disappearance of the most frequent side effect, cheilitis, was the same in the Tigason group and in the placebo group. This double-blind randomized clinical trial shows that Tigason at low doses is an efficient and well-tolerated maintenance treatment of psoriasis. [ABSTRACT FROM AUTHOR]
- Published
- 1985
- Full Text
- View/download PDF
92. Antigen-presenting properties of human epidermal cells compared with peripheral blood mononuclear cells.
- Author
-
Bagot, M., Heslan, M., Dubertret, L., Roujeau, J. C., Touraine, R., and Levy, J. P.
- Subjects
SKIN ,ANTIGENS ,EPIDERMIS ,DENDRITIC cells ,LYMPHOCYTES ,LYMPHOID tissue ,T cells - Abstract
The initiating event of several immune effector functions in the skin is the presentation of antigens to lymphoid immunocornpetent cells. Two kinds of antigen-presenting cells have been identified in normal human epidermis: Langerhans cells (LC) and indeterminate cells (Rowden, Phillips & Lewis, 1979). They display a dendritic morphology, bear class II HLA-DR molecules, and are necessary for T-cell activation and proliferation. The role of these epidermal dendritic cells in epidermal cell-lymphocyte interactions and their antigen-presenting proper- tics have been studied in vitro in the mixed epidermal cell-lymphocyte reaction (MECLR). [ABSTRACT FROM AUTHOR]
- Published
- 1985
- Full Text
- View/download PDF
93. The collagen lattice: a model for studying the physiology, biosynthetic function and pharmacology of the skin.
- Author
-
Coulomb, B., Dubertet, L., Merrill, C., Touraine, R., and Bell, E.
- Subjects
COLLAGEN ,PHYSIOLOGY ,CELL culture ,SKIN ,HUMAN anatomy ,CONNECTIVE tissues - Abstract
Until recently, changes in cell physiology following application of pharmacological agents have been studied in vivo or in vitro using monolayered cells. Although both approaches have unique advantages, both have shortcomings. Now the development of a skin-equivalent model has provided a system for studying cell responses at the tissue and organ levels in vitro (Bell, Ivarsson & Merrill, 1979; Bell et at, 1981a, b). The in vitro tissue model can he made simple or complex with respect to cell type heterogeneity and matrix constitution; ideally, however, it should resemble skin as closely as possible. It has the special advantage, unlike skin, of being able to survive for long periods in vitro. In this paper we compare the model morphologically with skin arid review some aspects of the biosynthetic output of cells in the tissue equivalent with that of monolavered cells. Finally we illustrate in a pharmacological study that the model can be used to provide new information that in vivo studies or monolayer cell studies cannot yield. [ABSTRACT FROM AUTHOR]
- Published
- 1984
- Full Text
- View/download PDF
94. Psoriasis: a defect in the regulation of epidermal proteases, as shown by serial biopsies after cantharidin application.
- Author
-
Dubertret, L., Bertaux, B., Fosse, M., and Touraine, R.
- Subjects
PSORIASIS ,SERINE proteinases ,PROTEINASES ,SKIN diseases ,CLINICAL pathology ,GRANULOCYTES - Abstract
The possible role of epidermal serine proteases in the genesis of psoriatic lesions was investigated by sequential biopsies of the epidermal damage induced by topical cantharidin. In the skin of normal subjects, epidermal damage was followed by the transient appearance of proteolytic activity in the upper epidermis accompanied by temporary hyperacanthosis and perivascular inflammatory cells in the superficial dermis. In the uninvolved skin of five patients with psoriasis this proteolysis persisted longer, for more than 7 days. Thereafter, in three of the patients, the proteolysis abated, and this was followed by disappearance of the hyperacanthosis and the dermal infiltrate; in the other two psoriatics the proteolysis and hyperacanthosis increased, and a typical Koebner phenomenon ensued. Migration of neutrophils into the epidermis occurred as a later event. Thus the abnormal persistence of proteolytic activity in the upper epidermis after cantharidin application distinguishes the normal from the psoriatic skin injury response and might initiate the psoriatic lesion. [ABSTRACT FROM AUTHOR]
- Published
- 1984
- Full Text
- View/download PDF
95. A routine immuno-electron microscopic technique for localizing an auto-antibody on epidermal basement membrane.
- Author
-
Prost, C., Dubertret, L., Fosse, M., Wechsler, J., and Touraine, R.
- Subjects
BASAL lamina ,ELECTRON microscopy ,MICROSCOPY ,ELECTRON microscopic diagnosis ,IMMUNOFLUORESCENCE ,IMMUNOGLOBULINS ,FLUORESCENCE - Abstract
A new diagnostic technique is describe, in which 0·7 mm thick slices of skin are freshly cut, thoroughly washed, slightly fixed and directly incubated in peroxidase-labelled antibodies. This easy technique allows routine immuno-electron microscopic diagnosis of subepidermal auto-immune bullous diseases, with excellent morphological results. [ABSTRACT FROM AUTHOR]
- Published
- 1984
- Full Text
- View/download PDF
96. Inhibition of neutrophil migration by etretinate and its main metabolite.
- Author
-
Dubertret, L., Lebreton, C., and Touraine, R.
- Subjects
RETINOIDS ,ETRETINATE ,TRETINOIN ,DERMATOLOGIC agents ,DERMATOPHARMACOLOGY ,DERMATOLOGY - Abstract
By using a very sensitive and reproducible skin chamber technique we have shown that the aromatic retinoid etretinate (Ro 10–9359) and its main metabolite (Ro 10–1670) significantly inhibit the migration of neutrophils from the blood to tissues when applied into skin chambers (0·1 mg/ml) or when given orally (1 mg/kg/day for 8 days) to normal volunteers. This pharmacological property could be closely linked to the antipsoriatic properties of these drugs. [ABSTRACT FROM AUTHOR]
- Published
- 1982
- Full Text
- View/download PDF
97. A cytochemical marker for epidermal differentiation, Langerhans cells, skin resident macrophages and mitochondria.
- Author
-
Dubertret, L., Breton-Gorius, J., Fosse, M., and Touraine, R.
- Subjects
LANGERHANS cells ,ENDOPLASMIC reticulum ,KERATINOCYTES ,PSORIATIC arthritis ,MITOCHONDRIA ,MUCOUS membranes ,SKIN ,DERMATOLOGY - Abstract
Incubation of unfixed and unfrozen slices of skin in diaminobenzidine allows visualization of peroxidatic activity in the perinuclear envelope and endoplasmic redculum of normal human Langerhans cells. A similar peroxidatic activity is observed in supra-basal keratinocytes undergoing orthokeratotic differentiation. Basal keratinocytes and melanocytes are always negative. This enzyme is absent in mucous and parakeratotic (psoriatic) differentiation. A peroxidatic activity was also found in the endoplasmic reticulum of normal resident skin macrophages. Mitochondria are also strongly stained by this technique and it was shown that the number of epidermal mitochondria is greatly increased in psoriatic lesions. [ABSTRACT FROM AUTHOR]
- Published
- 1982
- Full Text
- View/download PDF
98. Localization of proteolytic activity in psoriatic skin.
- Author
-
Dubertret, L., Bertaux, B., Fosse, M., and Touraine, R.
- Subjects
SKIN tests ,PROTEOLYSIS ,ENZYME inhibitors ,HYDROLASES ,PROTEOLYTIC enzymes ,PROTEIN metabolism - Abstract
Incubation of unfixed slices of skin for t h at 37°C in Hanks' medium allowed the expression of proteolytic activity in the upper keratinocyte layers in psoriatic lesions and, in some cases, in uninvolved skin of psoriatics, but never in normal skin. This proteolysis was inhibited by DFP and TLCK, known inhibitors of the neutral proteinase previously described as increased in psoriatic lesions. The topographical analysis of this proteolytic activity suggests that a disturbance of the protease-antiprotease equilibrium in human epidermis may be implicated in the appearance of psoriatic lesions. [ABSTRACT FROM AUTHOR]
- Published
- 1982
- Full Text
- View/download PDF
99. Cellular events leading to blister formation in bullous pemphigoid.
- Author
-
Dubertret, L., Bertaux, B., Fosse, M., and Touraine, R.
- Subjects
ENZYMES ,CATALYSTS ,GRANULOCYTES ,LEUCOCYTES ,SKIN diseases ,KILLER cells ,MACROPHAGES ,PROTEOLYTIC enzymes ,ELECTRON microscopy ,METALLOENZYMES - Abstract
Cellular events occurring in eight patients with bullous pemphigoid were studied by light and electron microscopy. Sections (0.5 μm) of large surface area, overlapping blisters and surrounding skin, were examined and correlated ultrastructural studies were performed on selected areas. The peroxidase contained in granules of neutrophils, eosinophils and young macrophages was visualized by incubation with diaminobenzidine and hydrogen peroxide. This cytochemical reaction was used as a marker to study the release of granule enzymes from these inflammatory cells. The release of such enzymes from eosinophils and occasionally from macrophages on the epidermal basement membrane (more precisely in the lamina lucida) was demonstrated in the skin surrounding the blisters in four patients. The release of these enzymes was also observed in the floor of the blisters in all eight patients. It is well known that these granules contain several proteolytic enzymes. These observations are therefore consistent with the proposal that proteolytic enzymes of eosinophils play a pathogenic role during the initial stages of blister formation in bullous pemphigoid. [ABSTRACT FROM AUTHOR]
- Published
- 1980
- Full Text
- View/download PDF
100. Endogenous peroxidases: a morphological and functional marker to study inflammatory skin diseases.
- Author
-
Dubertret, L., Bertaux, B., Fosse, M., and Touraine, R.
- Subjects
PEROXIDASE ,SKIN diseases ,SKIN inflammation ,PHOTOCHEMOTHERAPY ,DERMATOLOGY ,PHYSIOLOGICAL therapeutics - Abstract
The visualization of peroxidase positive lysosomes by diaminobenzidine plus H
2 O2 allowed easy identification of neutrophils, eosinophils, monocytes and young tissue macrophages in 0.2 μm to 0.5 μm skin plastic sections of large surface area. Evaluation of the lysosomal functions of these phagocytic cells was greatly improved by the possibility of correlating observations on the same cell at light and electron microscopic levels. [ABSTRACT FROM AUTHOR]- Published
- 1980
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.